Community Portal

A place for Clinicians and Healthcare Suppliers to share knowledge and learn more about THE CLINICIAN EXCHANGE

IN THE NEWS

CLINICIAN NEWS

Provided by: Medscape

Same-Session Angiography, Ad Hoc PCI Feasible for Select TAVRs

Published: Tue, 15 Aug 2017 16:32:13 EDT
The strategy, potentially more efficient and less costly than staged procedures, was also safe in the single-center study; observers point to possible advantages and pitfalls.
Medscape Medical News

CBO: Ending ACA Insurer Payments Would Add $194B to Deficit

Published: Tue, 15 Aug 2017 15:53:01 EDT
If insurers no longer are reimbursed for cost-sharing subsidies given to ACA enrollees, they'd be forced to raise premiums, translating into higher premium subsidies paid by the government.
News Alerts

Zika Linked to Rising Tide of Serious Neurologic Complications

Published: Tue, 15 Aug 2017 15:11:33 EDT
A rising tide of serious neurologic complications among adults in Brazil has been linked to the spread of the Zika virus, new research shows.
Medscape Medical News

Nonobstructive Coronary Plaque on Cardiac CT: Alarming or Not?

Published: Tue, 15 Aug 2017 14:43:47 EDT
This finding "requires action," a CT imager says, while a noninterventionalist counters there are no data showing improved outcomes by identifying nonobstructive plaque in healthy people, and there are downsides.
Medscape Medical News
Displaying results 13-16 (of 20)
 1 - 2 - 3 - 4 - 5 

HEALTHCARE SUPPLIER NEWS

What's next after CRISPR clears hurdle in quest to transplant pig organs into humans?

Published: Fri, 11 Aug 2017 18:31:19 +0000
A Boston biotech has used CRISPR to eliminate a family of viruses in pigs, which could pave the way for transplanting animal organs into humans. But scientists working in this field, known as xenotransplantation, still have plenty of hurdles to cross.

GSK jilts Ionis rare disease drug as FDA filing nears

Published: Fri, 11 Aug 2017 13:19:06 +0000
GlaxoSmithKline has jilted Ionis Pharmaceuticals just before the pair was due to file for approval of inotersen. The action furthers recently installed GSK CEO Emma Walmsley’s plan to purge the Big Pharma of its rare disease programs.

Takeda taps Texas startup for 'double whammy' cancer immunotherapies

Published: Fri, 11 Aug 2017 12:31:36 +0000
Austin, Texas-based startup Shattuck Labs is less than a year old but has already bagged its first big pharma partner with Japan's Takeda buying into its immuno-oncology platform.

NantHealth cuts staff, offloads assets as Q2 losses hit $70M

Published: Fri, 11 Aug 2017 08:58:36 +0000
NantHealth is cutting its headcount by 300 through layoffs and the sale of assets to Allscripts. The reduction, which amounts to about one-third of NantHealth’s headcount, will lower costs at the Patrick Soon-Shiong-helmed company after a quarter in which it lost $70 million.
Displaying results 13-16 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy
Top